Siri Aastedatter Sakya
0000-0002-5893-6771
3 papers found
Refreshing results…
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models
Missing publications? Search for publications with a matching author name.